Predicting hospitalization from real-world measures in patients with chronic kidney disease: A proof-of-principle study

Author:

Lyden Kate12ORCID,Abraham Nikita3,Boucher Robert3ORCID,Wei Guo34,Gonce Victoria3,Carle Judy3,Hartsell Sydney E.3ORCID,Christensen Jesse5,Beddhu Srinivasan35

Affiliation:

1. Department of Kinesiology, University of Massachusetts, Amherst, MA, USA

2. Department of Health and Exercise Science, Colorado State University, Fort Collins, CO, USA

3. Division of Nephrology & Hypertension, University of Utah School of Medicine, Salt Lake City, UT, USA

4. Division of Biostatistics, University of Utah School of Medicine, Salt Lake City, UT, USA

5. Medical Service, Veterans Affairs Salt Lake City Health Care System, Salt Lake City, UT, USA

Abstract

Objective To investigate if in-clinic measures of physical function and real-world measures of physical behavior and mobility effort are associated with one another and to determine if they predict future hospitalization in participants with chronic kidney disease (CKD). Methods In this secondary analysis, novel real-world measures of physical behavior and mobility effort, including the best 6-minute step count (B6SC), were derived from passively collected data from a thigh worn actigraphy sensor and compared to traditional in-clinic measures of physical function (e.g. 6-minute walk test (6MWT). Hospitalization status during 2 years of follow-up was determined from electronic health records. Correlation analyses were used to compare measures and Cox Regression analysis was used to compare measures with hospitalization. Results One hundred and six participants were studied (69  ±  13 years, 43% women). Mean  ±  SD baseline measures for 6MWT was 386  ±  66 m and B6SC was 524  ±  125 steps. Forty-four hospitalization events over 224 years of total follow-up occurred. Good separation was achieved for tertiles of 6MWT, B6SC and steps/day for hospitalization events. This pattern persisted in models adjusted for demographics (6MWT: HR  =  0.63 95% CI 0.43–0.93, B6SC: HR  =  0.75, 95% CI 0.56–1.02 and steps/day: HR  =  0.75, 95% CI 0.50–1.13) and further adjusted for morbidities (6MWT: HR  =  0.54, 95% CI 0.35–0.84, B6SC: HR  =  0.70, 95% CI 0.49–1.00 and steps/day: HR  =  0.69, 95% CI 0.43–1.09). Conclusion Digital health technologies can be deployed remotely, passively, and continuously to collect real-world measures of physical behavior and mobility effort that differentiate risk of hospitalization in patients with CKD.

Funder

National Heart, Lung, and Blood Institute

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

SAGE Publications

Subject

Health Information Management,Computer Science Applications,Health Informatics,Health Policy

Reference68 articles.

1. Commissioner O of the. 21st Century Cures Act. FDA, https://www.fda.gov/regulatory-information/selected-amendments-fdc-act/21st-century-cures-act (2020, accessed 11 October 2021).

2. Evidence from Pragmatic Trials during Routine Care — Slouching toward a Learning Health System

3. Core Concept: In the wake of COVID-19, decentralized clinical trials move to center stage

4. COVID-19 as a Catalyst for Modernizing Clinical Trials. Pfizer, https://www.pfizer.com/news/articles/covid_19_as_a_catalyst_for_modernizing_clinical_trials (accessed 31 December 2022).

5. COVID-19: The Great Decentralized Clinical Trials Accelerator. DIA Global Forum, https://globalforum.diaglobal.org/issue/september-2020/covid-19-the-great-decentralized-clinical-trials-accelerator/ (2020, accessed 23 January 2022).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3